GLP-1 receptor agonists, used to treat diabetes, are now also being used for obesity in children and adolescents.
Justine Magalona, PharmD candidate
Advertisement
Justine Magalona is a PharmD candidate at the Philadelphia College of Pharmacy at Saint Joseph’s University.
Articles by Justine Magalona, PharmD candidate
Advertisement
Latest Updated Articles
Advancements in FDA approvals for pediatric obesity treatmentPublished: July 14th 2023 | Updated:
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Parents weigh holiday traditions against COVID-19 risks, national poll shows
2
Thao Ly-Phan, MD, discusses how an integrated obesity care model can strengthen family engagement
3
Jonathan Strober, MD, highlights 'encouraging' nipocalimab-aahu data for generalized myasthenia gravis
4
Jonathan Flyer, MD, outlines strategies to boost pediatric lipid screenings
5
